Confronting the side effects of a common anti-cancer treatment

Results of a new study suggest that a new treatment approach is needed — and how this may be possible — to address adverse effects of aromatase inhibitors, drugs commonly prescribed to both men and women to prevent recurrence of estrogen-positive breast cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *